Hennion & Walsh Asset Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.33M Sell
2025
Q2
$2.35M Sell
2025
Q1
$2.69M Sell
2024
Q4
$4.04M Buy
2024
Q3
$4.49M Buy
2024
Q2
$2.33M Buy
2024
Q1
$1.92M Buy
2023
Q4
$1.65M Buy
2023
Q3
$416K Buy
2023
Q2
$340K Buy